BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 32620153)

  • 1. Outcomes assessment in intrahepatic cholangiocarcinoma using qualitative and quantitative imaging features.
    King MJ; Hectors S; Lee KM; Omidele O; Babb JS; Schwartz M; Tabrizian P; Taouli B; Lewis S
    Cancer Imaging; 2020 Jul; 20(1):43. PubMed ID: 32620153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of the histopathologic findings of intrahepatic cholangiocarcinoma: qualitative and quantitative assessment of diffusion-weighted imaging.
    Lewis S; Besa C; Wagner M; Jhaveri K; Kihira S; Zhu H; Sadoughi N; Fischer S; Srivastava A; Yee E; Mortele K; Babb J; Thung S; Taouli B
    Eur Radiol; 2018 May; 28(5):2047-2057. PubMed ID: 29234913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrahepatic cholangiocarcinoma: can imaging phenotypes predict survival and tumor genetics?
    Aherne EA; Pak LM; Goldman DA; Gonen M; Jarnagin WR; Simpson AL; Do RK
    Abdom Radiol (NY); 2018 Oct; 43(10):2665-2672. PubMed ID: 29492607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Performance and Prognostic Relevance of FDG Positron Emission Tomography/Computed Tomography for Patients with Extrahepatic Cholangiocarcinoma.
    Kim NH; Lee SR; Kim YH; Kim HJ
    Korean J Radiol; 2020 Dec; 21(12):1355-1366. PubMed ID: 32767862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of the albumin-bilirubin grade on long-term outcomes of CT-guided percutaneous microwave ablation in intrahepatic cholangiocarcinoma.
    Ni JY; An C; Zhang TQ; Huang ZM; Jiang XY; Huang JH
    Int J Hyperthermia; 2019; 36(1):328-336. PubMed ID: 30689465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrahepatic cholangiocarcinoma: MRI texture signature as predictive biomarkers of immunophenotyping and survival.
    Zhang J; Wu Z; Zhao J; Liu S; Zhang X; Yuan F; Shi Y; Song B
    Eur Radiol; 2021 Jun; 31(6):3661-3672. PubMed ID: 33245493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and Prognostic Role of 18-FDG PET/CT in the Management of Resectable Biliary Tract Cancer.
    Ma KW; Cheung TT; She WH; Chok KSH; Chan ACY; Dai WC; Chiu WH; Lo CM
    World J Surg; 2018 Mar; 42(3):823-834. PubMed ID: 28905105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI features predict microvascular invasion in intrahepatic cholangiocarcinoma.
    Ma X; Liu L; Fang J; Rao S; Lv L; Zeng M; Shi Y; Yang C
    Cancer Imaging; 2020 Jun; 20(1):40. PubMed ID: 32576283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction for early recurrence of intrahepatic mass-forming cholangiocarcinoma: quantitative magnetic resonance imaging combined with prognostic immunohistochemical markers.
    Zhao L; Ma X; Liang M; Li D; Ma P; Wang S; Wu Z; Zhao X
    Cancer Imaging; 2019 Jul; 19(1):49. PubMed ID: 31307551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machine learning-based Radiomics analysis for differentiation degree and lymphatic node metastasis of extrahepatic cholangiocarcinoma.
    Tang Y; Yang CM; Su S; Wang WJ; Fan LP; Shu J
    BMC Cancer; 2021 Nov; 21(1):1268. PubMed ID: 34819043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the Outcomes of Intrahepatic Cholangiocarcinoma After Ultrasound-Guided Percutaneous Microwave Ablation Based on Albumin-Bilirubin Grade.
    Yang H; Cheng Z; Han Z; Liu F; Yu X; Yu J; Liang P
    Cardiovasc Intervent Radiol; 2021 Feb; 44(2):261-270. PubMed ID: 33057809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline Volumetric Multiparametric MRI: Can It Be Used to Predict Survival in Patients with Unresectable Intrahepatic Cholangiocarcinoma Undergoing Transcatheter Arterial Chemoembolization?
    Pandey A; Pandey P; Ghasabeh MA; Zarghampour M; Khoshpouri P; Ameli S; Luo Y; Kamel IR
    Radiology; 2018 Dec; 289(3):843-853. PubMed ID: 30129899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apparent Diffusion Coefficient MRI Shows Association With Early Progression of Unresectable Intrahepatic Cholangiocarcinoma With Combined Targeted-Immunotherapy.
    Sheng R; Sun W; Huang X; Jin K; Gao S; Zeng M; Wu D; Shi G
    J Magn Reson Imaging; 2023 Jan; 57(1):275-284. PubMed ID: 35488518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging features based on CT and MRI for predicting prognosis of patients with intrahepatic cholangiocarcinoma: a single-center study and meta-analysis.
    Sun D; Xu Z; Cao S; Wu H; Lu M; Xu Q; Wang K; Ji G
    Cancer Imaging; 2023 Jun; 23(1):56. PubMed ID: 37287062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass-forming intrahepatic cholangiocarcinoma: Can diffusion-weighted imaging predict microvascular invasion?
    Zhou Y; Wang X; Xu C; Zhou G; Liu X; Gao S; Xu P
    J Magn Reson Imaging; 2019 Jul; 50(1):315-324. PubMed ID: 30444023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholangiocarcinoma: Correlation between Molecular Profiling and Imaging Phenotypes.
    Sadot E; Simpson AL; Do RK; Gonen M; Shia J; Allen PJ; D'Angelica MI; DeMatteo RP; Kingham TP; Jarnagin WR
    PLoS One; 2015; 10(7):e0132953. PubMed ID: 26207380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical Management of Intrahepatic Cholangiocarcinoma: Defining an Optimal Prognostic Lymph Node Stratification Schema.
    Kim Y; Spolverato G; Amini N; Margonis GA; Gupta R; Ejaz A; Pawlik TM
    Ann Surg Oncol; 2015 Aug; 22(8):2772-8. PubMed ID: 25663595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of
    Lim CH; Moon SH; Cho YS; Choi JY; Lee KH; Hyun SH
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1705-1712. PubMed ID: 31049603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incremental value of volumetric multiparametric MRI over Fudan score for prognosis of unresectable intrahepatic cholangiocarcinoma treated with systemic chemotherapy.
    Pandey A; Mohseni A; Shaghaghi M; Pandey P; Rezvani Habibabadi R; Hazhirkarzar B; Ly A; Panid Madani S; Borhani A; Kamel IR
    Eur J Radiol; 2024 Jan; 170():111196. PubMed ID: 38029705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the 8th edition American Joint Commission on Cancer (AJCC) staging system for patients with intrahepatic cholangiocarcinoma: A surveillance, epidemiology, and end results (SEER) analysis.
    Kim Y; Moris DP; Zhang XF; Bagante F; Spolverato G; Schmidt C; Dilhoff M; Pawlik TM
    J Surg Oncol; 2017 Nov; 116(6):643-650. PubMed ID: 28608424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.